Plasma half-lives and bioavailability of human monoclonal Rh D antibodies BRAD-3 and BRAD-5 following intramuscular injection into Rh D-negative volunteersJean Goodrick, D J Anstee, Belinda M. Kumpel et al.|Clinical & Experimental Immunology|1994Cited by 44
Radio‐Immunoassay of the Functional Activity of Anti‐D (Rh) Preparations using a Human Monoclonal <sup>125</sup>I‐Labelled Anti‐DN.C. Hughes‐Jones, K. M. Thompson, Ruth J. Pepper et al.|Vox Sanguinis|1987Cited by 10